TickerFactsScreenerDevelopers

Krystal Biotech, Inc. (KRYS) — Operating Income

Annual figures by fiscal year, from SEC filings.

2016: -$1.14M2017: -$4.77M2018: -$11.92M2019: -$22.08M2020: -$33.00M2021: -$68.28M2022: -$145.20M2023: -$109.62M2024: $65.75M2025: $161.29M$161.29M
2016Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$161.29M+145.3%
2024$65.75M+160.0%
2023-$109.62M+24.5%
2022-$145.20M-112.7%
2021-$68.28M-106.9%
2020-$33.00M-49.4%
2019-$22.08M-85.3%
2018-$11.92M-149.7%
2017-$4.77M-317.5%
2016-$1.14M—